Limited expression of reticulocalbin-1 in lymphatic endothelial cells in lung tumor but not in normal lung

Biochemical and Biophysical Research Communications

Volumn 405, Issue 4, 2011, Pages 610-614

  Yoshida, Yasunobu ^a,b   Yamashita, Takuya ^a,b   Nagano, Kazuya ^a   Imai, Sunao ^a   Nabeshi, Hiromi ^a,b   Yoshikawa, Tomoaki ^a,b   Yoshioka, Yasuo ^a,b   Abe, Yasuhiro ^a   Kamada, Haruhiko ^a,b   Tsutsumi, Yasuo ^a,b   Tsunoda, Shin ichi ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Lung cancer; Lymph node metastasis; Proteomics; Reticulocalbin 1; Tumor lymphatic endothelial cells

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; PODOPLANIN; PROTEIN; RETICULOCALBIN 1; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHATIC ENDOTHELIAL CELLS IN TUMOR; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHATIC VESSELS; TISSUE ARRAY ANALYSIS;

EID: 79951953222     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.077     Document Type: Article

References (37)

1. Celikoglu F., Celikoglu S.I., Goldberg E.P. Intratumoural chemotherapy of lung cancer for diagnosis and treatment of draining lymph node metastasis. J. Pharm. Pharmacol. 2010, 62:287-295.
2. Elsheikh M.N., Rinaldo A., Hamakawa H., Mahfouz M.E., Rodrigo J.P., Brennan J., Devaney K.O., Grandis J.R., Ferlito A. Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma. Head Neck 2006, 28:842-849.
3. Konno H., Tanaka T., Baba M., Kanai T., Nakamura S. Antiangiogenic therapy for liver metastasis of gastrointestinal malignancies. J. Hepatobiliary Pancreat. Surg. 1999, 6:1-6.
4. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
5. Mahadevan V., Hart I.R. Metastasis and angiogenesis. Acta Oncol. 1990, 29:97-103.
6. Hepburn P.J., Griffiths K., Harper M.E. Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitro. Prostate 1997, 33:123-132.
7. Li A., Li H., Zhang J., Jin G., Xiu R. The mitogenic and anti-apoptotic activity of tumor conditioned medium on endothelium. Clin. Hemorheol. Microcirc. 2003, 29:375-382.
8. Yang Q.R., Smets R.M., Neetens A., Vanden Berghe D. Human retinal pigment epithelial cells from different donors continuously produce a vascular endothelial cell-stimulating factor into serum-free medium. J. Cell Sci. 1993, 104(Pt 1):211-218.
9. Carson-Walter E.B., Watkins D.N., Nanda A., Vogelstein B., Kinzler K.W., St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 2001, 61:6649-6655.
10. Fuchs B., Mahlum E., Halder C., Maran A., Yaszemski M., Bode B., Bolander M., Sarkar G. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene 2007, 399:137-143.
11. Huminiecki L., Gorn M., Suchting S., Poulsom R., Bicknell R. Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics 2002, 79:547-552.
12. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 1992, 187:1579-1586.
13. Yamaji Y., Yoshida S., Ishikawa K., Sengoku A., Sato K., Yoshida A., Kuwahara R., Ohuchida K., Oki E., Enaida H., Fujisawa K., Kono T., Ishibashi T. TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2008, 49:3151-3157.
14. Chen H.X., Gore-Langton R.E., Cheson B.D. Clinical trials referral resource: current clinical trials of the anti-VEGF monoclonal antibody bevacizumab. Oncology (Williston Park) 2001, 15. 1017, 1020, 1023-6.
15. Shinkaruk S., Bayle M., Lain G., Deleris G. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Curr. Med. Chem. Anticancer Agents 2003, 3:95-117.
16. Djoneidi M., Brodt P. Isolation and characterization of rat lymphatic endothelial cells. Microcirc. Endothelium Lymphatics 1991, 7:161-182.
17. Leak L.V., Jones M. Lymphangiogenesis in vitro: formation of lymphatic capillary-like channels from confluent monolayers of lymphatic endothelial cells. In Vitro Cell Dev. Biol. Anim. 1994, 30A:512-518.
18. Donoghue J.F., Lederman F.L., Susil B.J., Rogers P.A. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum. Reprod. 2007, 22:1705-1713.
19. Omachi T., Kawai Y., Mizuno R., Nomiyama T., Miyagawa S., Ohhashi T., Nakayama J. Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance. Cancer Lett. 2007, 246:167-172.
20. Hanash S. Disease proteomics. Nature 2003, 422:226-232.
21. Page M.J., Amess B., Rohlff C., Stubberfield C., Parekh R. Proteomics: a major new technology for the drug discovery process. Drug Discov. Today 1999, 4:55-62.
22. Teraoka S., Kyoizumi S., Seyama T., Yamakido M., Akiyama M. A novel SCID mouse model for studying spontaneous metastasis of human lung cancer to human tissue. Jpn. J. Cancer Res. 1995, 86:419-423.
23. Thelen A., Scholz A., Benckert C., Weichert W., Dietz E., Wiedenmann B., Neuhaus P., Jonas S. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann. Surg. Oncol. 2008, 15:791-799.
24. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., Diem K., Weninger W., Tschachler E., Alitalo K., Kerjaschki D. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 1999, 154:385-394.
25. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V.W., Fang G.H., Dumont D., Breitman M., Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 1995, 92:3566-3570.
26. Trojan L., Michel M.S., Rensch F., Jackson D.G., Alken P., Grobholz R. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J. Urol. 2004, 172:103-107.
27. Ozawa M. Cloning of a human homologue of mouse reticulocalbin reveals conservation of structural domains in the novel endoplasmic reticulum resident Ca(2+)-binding protein with multiple EF-hand motifs. J. Biochem. 1995, 117:1113-1119.
28. Ozawa M., Muramatsu T. Reticulocalbin, a novel endoplasmic reticulum resident Ca(2+)-binding protein with multiple EF-hand motifs and a carboxyl-terminal HDEL sequence. J. Biol. Chem. 1993, 268:699-705.
29. Yu L.R., Zeng R., Shao X.X., Wang N., Xu Y.H., Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 2000, 21:3058-3068.
30. Liu Z., Brattain M.G., Appert H. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem. Biophys. Res. Commun. 1997, 231:283-289.
31. Ozawa K., Kuwabara K., Tamatani M., Takatsuji K., Tsukamoto Y., Kaneda S., Yanagi H., Stern D.M., Eguchi Y., Tsujimoto Y., Ogawa S., Tohyama M. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J. Biol. Chem. 1999, 274:6397-6404.
32. Gaillard C., Cabannes E., Strauss F. Identity of the RNA-binding protein K of hnRNP particles with protein H16, a sequence-specific single strand DNA-binding protein. Nucleic Acids Res. 1994, 22:4183-4186.
33. Ostrowski J., Klimek-Tomczak K., Wyrwicz L.S., Mikula M., Schullery D.S., Bomsztyk K. Heterogeneous nuclear ribonucleoprotein K enhances insulin-induced expression of mitochondrial UCP2 protein. J. Biol. Chem. 2004, 279:54599-54609.
34. Stojadinovic A., Hooke J.A., Shriver C.D., Nissan A., Kovatich A.J., Kao T.C., Ponniah S., Peoples G.E., Moroni M. HYOU1/Orp150 expression in breast cancer. Med. Sci. Monit 2007, 13. BR231-239.
35. Slaby O., Sobkova K., Svoboda M., Garajova I., Fabian P., Hrstka R., Nenutil R., Sachlova M., Kocakova I., Michalek J., Smerdova T., Knoflickova D., Vyzula R. Significant over expression of Hsp110 gene during colorectal cancer progression. Oncol. Rep. 2009, 21:1235-1241.
36. Hamrita B., Chahed K., Kabbage M., Guillier C.L., Trimeche M., Chaieb A., Chouchane L. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). Clin. Chim. Acta 2008, 393:95-102.
37. Cooper C.R., Graves B., Pruitt F., Chaib H., Lynch J.E., Cox A.K., Sequeria L., van Golen K.L., Evans A., Czymmek K., Bullard R.S., Donald C.D., Sol-Church K., Gendernalik J.D., Weksler B., Farach-Carson M.C., Macoska J.A., Sikes R.A., Pienta K.J. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J. Cell Biochem. 2008, 104:2298-2309.